Alternative to Basaglar in Serbia
The best equivalent of Basaglar in Serbia called Lantus (Insulin Glargine). Analogue has exactly the same ingredients, pharmacological group, treatment option
You can buy Lantus (Insulin Glargine) (alternative to Basaglar ) in pharmacies of Serbia.
Attention! Always consult to a doctor or pharmacist before using pills or medicines.
Where to buy
USA
Ingredients
Insulin Glargine
Treatment option
Pharmacological group
equal
equal
equal

Serbia
Ingredients equal
Insulin Glargine
Treatment option equal
Pharmacological group equal
Where to buy Basaglar or alternative in Serbia
To buy Basaglar or its alternatives in Serbia, we recommend to contact your nearest pharmacy. Call the pharmacy using the number on the map, to find out if Basaglar is in stock. Remember to ask the pharmacist about the price of the medicine and the requirement to provide a prescription, many medicines in Serbia are sold strictly according to the doctor's prescription. Show pharmacy near me.
Show pharmacy near me
Pillintrip.com is not a pharmacy!
Advertisements
Advertisements
Other analogues
| Name | Ingredients | Treatment option | Pharmacological group | ||
| Lantus (Insulin Glargine) | 100% | ||||
| Lantus | 100% | ||||
| 80% | |||||
| 80% | |||||
| 80% | |||||
| Amaryl | 80% | ||||
| Apidra (INSULIN GLULISINE) | 80% | ||||
| Glibomet | 80% | ||||
| Gliclada | 80% | ||||
| Glucobay | 80% | ||||
| Glucotrol XL | 80% | ||||
| Glucovance | 80% | ||||
| Gluformin | 80% | ||||
| Humalog | 80% | ||||
| Januvia | 80% | ||||
| Levemir | 80% | ||||
| Limeral | 80% | ||||
| Metfogamma | 80% | ||||
| NovoRapid | 80% | ||||
| Oglition | 80% | ||||
| Reguly | 80% | ||||
| Siofor | 80% | ||||
| Trical | 80% | ||||
| Apidra | 80% | ||||
| Diaprel MR | 80% | ||||
| Glikosan | 80% | ||||
| Glioral | 80% | ||||
| Humalog Mix 50 (Insulin Lispro) | 80% | ||||
| Maninil | 80% | ||||
| NovoMix 30 (Insulin Aspart) | 80% | ||||
| NovoMix 50 (Insulin Aspart) | 80% | ||||
| Tefor | 80% | ||||
| Janumet | 60% | ||||
| NovoMix 50 | 60% |
Advertisements
Advertisements
Advertisements
Advertisements





